Explore the words cloud of the LysoMod project. It provides you a very rough idea of what is the project "LysoMod" about.
The following table provides information about the project.
| Coordinator | 
		INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 
			 Organization address contact info  | 
	
| Coordinator Country | Portugal [PT] | 
| Project website | https://lysomod.wixsite.com/lysomod | 
| Total cost | 1˙156˙500 € | 
| EC max contribution | 1˙102˙500 € (95%) | 
| Programme | 
	1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge) | 
	
| Code Call | H2020-MSCA-RISE-2016 | 
| Funding Scheme | MSCA-RISE | 
| Starting year | 2017 | 
| Duration (year-month-day) | from 2017-03-01 to 2021-02-28 | 
Take a look of project's partnership.
LysoMod will innovate in the area of personalized medicine for disorders linked to lysosomal dysfunction. This will be achieved by implementing a collaborative staff-exchange program between highly complementary and multidisciplinary academic and non-academic partners with expertise in pharmacology, medicinal chemistry, cell biology, biochemistry, mouse and human genetics, transcriptomics, proteomics and lipidomics. Based on the critical role that lysosomes play in cells, a better understanding of lysosomal function will have a major impact on human health, fostering the development of new strategies to improve quality of life for people affected by a variety of diseases, ranging from lysosomal storage diseases (LSDs) to age-related neurodegenerative disorders. LysoMod’s specific objectives are: 1) to develop and further optimize existing therapies for LSDs; 2) to identify new targets for personalized therapies for LSDs; and 3) to investigate the cross-talk between lysosomal function, signalling pathways and gene expression regulation. The pioneer work of a participant in the consortium led to the development of a drug that is approved for clinical use. LysoMod will i) investigate the mechanisms of action of this and other drugs in lysosome-related disorder; ii) identify modifier genes involved in LSD pathology and test their potential as new targets for personalized therapeutic approaches; iii) identify candidate RNAs that can be targeted to enhance lysosomal function. The companies in the consortium will ensure a rapid transfer of new knowledge into applications for diagnostics and clinical trials. Prioritising lysosomal dysfunction as a highly relevant biomedical problem, the LysoMod consortium will implement a mentored staff-exchange program to provide young researchers with high-level training in innovative approaches for exploring biological systems, preparing the next generation of researchers for careers either in the private or public health sectors.
| Organization of a summer school in Chile | Other | 2020-03-03 15:05:06 | 
| Project Website Internet-based social media | Websites, patent fillings, videos etc. | 2020-03-03 15:05:06 | 
Take a look to the deliverables list in detail: detailed list of LysoMod deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LYSOMOD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "LYSOMOD" are provided by the European Opendata Portal: CORDIS opendata.